We demonstrated HDR-based correction of a G-to-A mutation in 10% of OTC alleles in the livers of newborn spfash mice, which provide a model of chronic hyperammonemia, and clinical benefits following in vivo genome editing. This evidence concerns the gene OTC and Hyperammonemia.